Biotech Deal News, Inside ETFs, Next Round of NAFTA Talks, Red Lobster CEO

Tatiana Darie, Bloomberg News Health Care Stocks Reporter, breaks down biotech deals for Celgene and Sanofi. Michael Jones, President and CEO at RiverFront Investment, discusses the advantages of investing in exchange traded funds. Fred Hochberg, Former Chairman a President of Export-Import Bank of The U.S., shares his thoughts on the next round of NAFTA negotiations. Red Lobster CEO Kim Lopdrup discusses leading sustainability in the seafood business. And Carol andBloomberg Stocks Editor Dave Wilson hit today’s “Movers and Shakers” and the “Stock of the Day.” 

2356 232